LACOSAMIDE

LACOSAMIDE was reported 37920 times

LACOSAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEW ONSET REFRACTORY STATUS EPILEPTICUS 56 0.5091
1 EPILEPSIA PARTIALIS CONTINUA 21 0.5000
2 AUTOMATISM EPILEPTIC 18 0.5000
3 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 15 0.4839
4 MITOCHONDRIAL DNA MUTATION 38 0.4419
5 MULTIPLE-DRUG RESISTANCE 828 0.2668
6 TUBEROUS SCLEROSIS COMPLEX 28 0.2667
7 BRAIN LOBECTOMY 15 0.2542
8 ANGIOFIBROMA 16 0.2162
9 CSF OLIGOCLONAL BAND PRESENT 26 0.2000
10 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 105 0.1959
11 FOCAL DYSCOGNITIVE SEIZURES 217 0.1905
12 HIPPOCAMPAL SCLEROSIS 24 0.1875
13 VAGAL NERVE STIMULATOR IMPLANTATION 57 0.1863
14 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 86 0.1838
15 SEIZURE CLUSTER 148 0.1785
16 CHANGE IN SEIZURE PRESENTATION 115 0.1777
17 POSTICTAL PSYCHOSIS 26 0.1667
18 CEREBRAL SALT-WASTING SYNDROME 16 0.1616
19 POSTICTAL PARALYSIS 37 0.1529
20 INTESTINAL ATRESIA 15 0.1389
21 PARTIAL SEIZURES 682 0.1301
22 CATARACT CONGENITAL 21 0.1243
23 ATONIC SEIZURES 104 0.1211
24 STATUS EPILEPTICUS 1291 0.1142
25 NEUROPROSTHESIS IMPLANTATION 15 0.1079
26 ELECTROCARDIOGRAM PR PROLONGATION 75 0.0980
27 MYOCARDIAL DEPRESSION 25 0.0969
28 ORGANIC BRAIN SYNDROME 18 0.0957
29 AURA 173 0.0927
30 PROPOFOL INFUSION SYNDROME 61 0.0865
31 BRAIN TUMOUR OPERATION 17 0.0850
32 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 53 0.0815
33 PETIT MAL EPILEPSY 410 0.0802
34 MYOCLONIC EPILEPSY 120 0.0791
35 BRAIN OPERATION 179 0.0783
36 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 29 0.0763
37 SIMPLE PARTIAL SEIZURES 61 0.0754
38 GENERALISED TONIC-CLONIC SEIZURE 1210 0.0730
39 CONGENITAL APLASIA 22 0.0707
40 TONIC CONVULSION 99 0.0698
41 LENNOX-GASTAUT SYNDROME 15 0.0661
42 COMPLEX PARTIAL SEIZURES 71 0.0638
43 DEJA VU 17 0.0618
44 SEIZURE 6980 0.0604
45 DRUG WITHDRAWAL CONVULSIONS 98 0.0551
46 FOETAL MALFORMATION 55 0.0506
47 DRUG-GENETIC INTERACTION 18 0.0504
48 BLOOD GASES ABNORMAL 27 0.0501
49 COARCTATION OF THE AORTA 47 0.0487
50 EPILEPSY 1466 0.0479
51 ANTICONVULSANT DRUG LEVEL INCREASED 77 0.0476
52 DROP ATTACKS 28 0.0471
53 TEMPORAL LOBE EPILEPSY 20 0.0458
54 PLEOCYTOSIS 26 0.0447
55 POSTICTAL STATE 45 0.0433
56 NECROSIS ISCHAEMIC 20 0.0433
57 COVID-19 IMMUNISATION 35 0.0419
58 VANISHING BILE DUCT SYNDROME 45 0.0404
59 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 200 0.0390
60 PSYCHOGENIC SEIZURE 36 0.0385
61 CYTOGENETIC ABNORMALITY 43 0.0381
62 POLYDACTYLY 44 0.0379
63 ENCEPHALITIS AUTOIMMUNE 46 0.0350
64 BRADYCARDIA NEONATAL 44 0.0350
65 CONGENITAL HYDRONEPHROSIS 25 0.0350
66 ELECTROENCEPHALOGRAM ABNORMAL 108 0.0342
67 SINUS NODE DYSFUNCTION 62 0.0338
68 BEHAVIOUR DISORDER 183 0.0338
69 ANTICONVULSANT DRUG LEVEL DECREASED 47 0.0333
70 INFANTILE SPASMS 24 0.0332
71 CEREBELLAR ATROPHY 29 0.0329
72 CLONIC CONVULSION 24 0.0328
73 HYPERAMMONAEMIC ENCEPHALOPATHY 56 0.0322
74 GLIOBLASTOMA 52 0.0304
75 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 33 0.0300
76 MACROGLOSSIA 15 0.0273
77 ATRIOVENTRICULAR BLOCK COMPLETE 180 0.0269
78 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 20 0.0266
79 EXCESSIVE EYE BLINKING 39 0.0264
80 MATERNAL EXPOSURE BEFORE PREGNANCY 180 0.0263
81 LARYNGEAL STENOSIS 15 0.0260
82 CRYPTORCHISM 29 0.0258
83 GAZE PALSY 43 0.0252
84 ABDOMINAL COMPARTMENT SYNDROME 16 0.0251
85 INTELLECTUAL DISABILITY 37 0.0244
86 SELF-DESTRUCTIVE BEHAVIOUR 21 0.0241
87 DEVELOPMENTAL HIP DYSPLASIA 20 0.0240
88 ATRIOVENTRICULAR BLOCK FIRST DEGREE 103 0.0237
89 ATRIOVENTRICULAR BLOCK SECOND DEGREE 72 0.0237
90 CHOLESTATIC LIVER INJURY 52 0.0233
91 HYPERAMMONAEMIA 113 0.0226
92 ATAXIA 266 0.0224
93 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
94 WHITE MATTER LESION 28 0.0222
95 GENE MUTATION 42 0.0212
96 ATRIOVENTRICULAR BLOCK 163 0.0211
97 SINUS ARREST 33 0.0210
98 MUCOSAL ULCERATION 21 0.0209
99 MATERNAL EXPOSURE DURING BREAST FEEDING 83 0.0204
100 BRUGADA SYNDROME 21 0.0203
101 GRAND MAL CONVULSION 187 0.0202
102 SUPERINFECTION 29 0.0193
103 PRODUCT AVAILABILITY ISSUE 435 0.0191
104 SOLILOQUY 16 0.0185
105 NYSTAGMUS 98 0.0184
106 URGE INCONTINENCE 16 0.0184
107 SPINA BIFIDA 38 0.0182
108 STARING 44 0.0182
109 WRONG PATIENT RECEIVED PRODUCT 53 0.0181
110 LIP INJURY 23 0.0175
111 CONDUCTION DISORDER 32 0.0174
112 CLEFT PALATE 33 0.0171
113 METABOLIC ENCEPHALOPATHY 51 0.0170
114 MYOCLONUS 201 0.0168
115 DIPLOPIA 431 0.0166
116 SLEEP DEFICIT 35 0.0165
117 CONVULSION 937 0.0164
118 GASTROSTOMY 25 0.0161
119 HYPERNATRAEMIA 80 0.0160
120 FEBRILE CONVULSION 19 0.0156
121 BRAIN NEOPLASM 141 0.0153
122 HYPERKINESIA 30 0.0141
123 QUADRIPARESIS 23 0.0138
124 TONIC CLONIC MOVEMENTS 18 0.0138
125 VENTRICULAR ARRHYTHMIA 50 0.0137
126 BRAIN NEOPLASM MALIGNANT 61 0.0136
127 CRANIOCEREBRAL INJURY 40 0.0132
128 SINUS BRADYCARDIA 125 0.0129
129 FEBRILE INFECTION 15 0.0127
130 INTRUSIVE THOUGHTS 15 0.0127
131 NEUROLOGICAL DECOMPENSATION 29 0.0125
132 ATRIAL SEPTAL DEFECT 102 0.0122
133 CLUMSINESS 33 0.0121
134 ENCEPHALITIS 83 0.0120
135 DRUG RESISTANCE 308 0.0120
136 NODAL RHYTHM 17 0.0116
137 LANGUAGE DISORDER 25 0.0116
138 AFFECTIVE DISORDER 90 0.0114
139 AGGRESSION 571 0.0114
140 PNEUMONIA ASPIRATION 281 0.0112
141 BLOOD LACTIC ACID INCREASED 59 0.0112
142 TONGUE BITING 23 0.0111
143 MUTISM 16 0.0110
144 PRODUCT DISPENSING ISSUE 47 0.0110
145 BRADYARRHYTHMIA 18 0.0109
146 ACUTE PSYCHOSIS 27 0.0109
147 HEAD TITUBATION 15 0.0109
148 FEELING DRUNK 79 0.0106
149 CLONUS 29 0.0106
150 AMMONIA INCREASED 54 0.0106
151 INABILITY TO AFFORD MEDICATION 105 0.0106
152 RESPIRATORY ACIDOSIS 41 0.0104
153 GASTROINTESTINAL TUBE INSERTION 26 0.0104
154 SLOW SPEECH 25 0.0103
155 ILLUSION 17 0.0103
156 PRESCRIBED OVERDOSE 196 0.0101
157 CEREBELLAR SYNDROME 22 0.0100
158 STILLBIRTH 48 0.0099
159 TOXIC ENCEPHALOPATHY 50 0.0099
160 POSTURE ABNORMAL 32 0.0098
161 SEDATION COMPLICATION 25 0.0098
162 FACE INJURY 37 0.0097
163 BUNDLE BRANCH BLOCK LEFT 41 0.0097
164 LICHENOID KERATOSIS 22 0.0096
165 ENCEPHALOPATHY 236 0.0096
166 BUNDLE BRANCH BLOCK RIGHT 44 0.0096
167 COGNITIVE DISORDER 447 0.0096
168 CEREBRAL ATROPHY 38 0.0095
169 INAPPROPRIATE AFFECT 15 0.0095
170 BRAIN DEATH 29 0.0094
171 DRUG TITRATION ERROR 24 0.0093
172 PSYCHOMOTOR RETARDATION 26 0.0092
173 PERSECUTORY DELUSION 23 0.0092
174 PSYCHOMOTOR SKILLS IMPAIRED 24 0.0092
175 DRUG LEVEL DECREASED 93 0.0091
176 HOMICIDAL IDEATION 37 0.0091
177 DRUG LEVEL INCREASED 150 0.0091
178 MATERNAL EXPOSURE DURING PREGNANCY 799 0.0090
179 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 490 0.0089
180 PREMATURE DELIVERY 142 0.0089
181 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 227 0.0088
182 HEAD INJURY 279 0.0088
183 LOGORRHOEA 31 0.0088
184 LAZINESS 15 0.0088
185 LEARNING DISORDER 21 0.0087
186 ACCIDENTAL DEATH 16 0.0086
187 PREGNANCY 171 0.0085
188 BRADYPNOEA 23 0.0085
189 OPTIC NEUROPATHY 18 0.0085
190 HOSPICE CARE 83 0.0084
191 CEREBRAL DISORDER 62 0.0084
192 MUSCLE CONTRACTURE 17 0.0084
193 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 32 0.0084
194 APHASIA 252 0.0083
195 PSYCHOTIC SYMPTOM 17 0.0082
196 ELECTRIC SHOCK SENSATION 23 0.0082
197 CARDIOTOXICITY 73 0.0082
198 EYE MOVEMENT DISORDER 56 0.0082
199 BICYTOPENIA 16 0.0082
200 DROOLING 56 0.0081
201 SEDATION 212 0.0081
202 PERSONALITY CHANGE 75 0.0081
203 TYPE IV HYPERSENSITIVITY REACTION 22 0.0080
204 ANTINUCLEAR ANTIBODY POSITIVE 26 0.0080
205 DEPRESSIVE SYMPTOM 28 0.0079
206 POLYDIPSIA 31 0.0078
207 BRAIN OEDEMA 99 0.0078
208 PATENT DUCTUS ARTERIOSUS 31 0.0078
209 BRADYCARDIA 414 0.0078
210 ABNORMAL BEHAVIOUR 309 0.0078
211 HAEMATOLOGICAL INFECTION 19 0.0078
212 THROMBOTIC MICROANGIOPATHY 75 0.0077
213 BRAIN INJURY 77 0.0077
214 COORDINATION ABNORMAL 107 0.0077
215 ALTERED STATE OF CONSCIOUSNESS 165 0.0076
216 SOMNOLENCE 1521 0.0075
217 LOW BIRTH WEIGHT BABY 60 0.0075
218 DYSPHEMIA 33 0.0075
219 PRODUCT ADMINISTRATION INTERRUPTED 59 0.0075
220 IRRITABILITY 450 0.0075
221 HOSTILITY 19 0.0075
222 BRADYKINESIA 44 0.0074
223 INTESTINAL ISCHAEMIA 41 0.0074
224 SCREAMING 47 0.0074
225 EXPOSURE VIA BREAST MILK 29 0.0073
226 THERAPY INTERRUPTED 517 0.0072
227 DYSMORPHISM 17 0.0072
228 RASH MORBILLIFORM 20 0.0072
229 IMPULSIVE BEHAVIOUR 27 0.0072
230 VENTRICULAR TACHYCARDIA 117 0.0071
231 ANGER 239 0.0071
232 TRICUSPID VALVE INCOMPETENCE 56 0.0070
233 FOETAL EXPOSURE DURING PREGNANCY 571 0.0070
234 ABORTION INDUCED 66 0.0070
235 DEPRESSED LEVEL OF CONSCIOUSNESS 276 0.0070
236 BALANCE DISORDER 603 0.0070
237 PSYCHOTIC DISORDER 204 0.0069
238 DYSARTHRIA 260 0.0069
239 COMA SCALE ABNORMAL 20 0.0069
240 ABORTION SPONTANEOUS 274 0.0068
241 HAEMODYNAMIC INSTABILITY 52 0.0068
242 PARADOXICAL DRUG REACTION 25 0.0068
243 HYPERTRANSAMINASAEMIA 47 0.0068
244 HYPERBILIRUBINAEMIA 70 0.0068
245 CALCINOSIS 15 0.0067
246 TRIGEMINAL NEURALGIA 27 0.0067
247 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 22 0.0066
248 HALLUCINATION, VISUAL 139 0.0066
249 SKIN ABRASION 31 0.0066
250 CLAVICLE FRACTURE 25 0.0065
251 URINE OUTPUT INCREASED 17 0.0065
252 PSYCHIATRIC SYMPTOM 48 0.0065
253 DRUG INTERACTION 1026 0.0065
254 HYPERSOMNIA 185 0.0064
255 CERVICAL VERTEBRAL FRACTURE 22 0.0064
256 AREFLEXIA 17 0.0064
257 CONCUSSION 49 0.0063
258 MOOD SWINGS 201 0.0063
259 HEPATIC CYTOLYSIS 80 0.0063
260 CHOLESTASIS 120 0.0062
261 DIABETES INSIPIDUS 15 0.0062
262 PULSELESS ELECTRICAL ACTIVITY 26 0.0062
263 COMA 295 0.0062
264 BRADYPHRENIA 40 0.0061
265 PERSONALITY DISORDER 16 0.0061
266 SELF-MEDICATION 25 0.0061
267 OVERDOSE 1309 0.0061
268 SPEECH DISORDER 317 0.0060
269 AGITATION 444 0.0060
270 HEPATOCELLULAR INJURY 85 0.0060
271 MIXED LIVER INJURY 18 0.0060
272 AMNESIA 389 0.0060
273 PRODUCT DISTRIBUTION ISSUE 55 0.0059
274 MUSCLE TWITCHING 136 0.0059
275 FACIAL BONES FRACTURE 21 0.0058
276 HYPOVENTILATION 19 0.0058
277 CAESAREAN SECTION 67 0.0057
278 METABOLIC ACIDOSIS 183 0.0057
279 THROMBOPHLEBITIS 20 0.0057
280 HYDROCEPHALUS 31 0.0057
281 ANXIETY DISORDER 19 0.0057
282 INTENTIONAL OVERDOSE 364 0.0057
283 RHINOVIRUS INFECTION 22 0.0056
284 INSURANCE ISSUE 86 0.0056
285 DRUG LEVEL BELOW THERAPEUTIC 31 0.0056
286 VENTRICULAR HYPOKINESIA 18 0.0056
287 STUPOR 18 0.0056
288 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 57 0.0055
289 PREMATURE BABY 167 0.0055
290 ELECTROCARDIOGRAM QT PROLONGED 199 0.0055
291 COMMUNICATION DISORDER 21 0.0055
292 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16 0.0055
293 STRABISMUS 16 0.0054
294 SMALL FOR DATES BABY 27 0.0054
295 THERAPEUTIC PRODUCT INEFFECTIVE 21 0.0054
296 NEUROTOXICITY 95 0.0054
297 ACIDOSIS 41 0.0054
298 ENDOTRACHEAL INTUBATION 15 0.0053
299 NORMAL NEWBORN 29 0.0053
300 CARDIAC ARREST 438 0.0053
301 SUICIDAL BEHAVIOUR 22 0.0053
302 HEMIPLEGIA 44 0.0053
303 MEMORY IMPAIRMENT 725 0.0053
304 WHEELCHAIR USER 23 0.0052
305 REHABILITATION THERAPY 20 0.0052
306 HYPONATRAEMIA 290 0.0051
307 BLOOD SODIUM DECREASED 97 0.0051
308 ATRIAL FLUTTER 41 0.0051
309 SUICIDE ATTEMPT 311 0.0051
310 MOTOR DYSFUNCTION 52 0.0051
311 INTENTIONAL PRODUCT MISUSE 445 0.0051
312 HEMIPARESIS 85 0.0050
313 ATTENTION DEFICIT HYPERACTIVITY DISORDER 21 0.0050
314 UNRESPONSIVE TO STIMULI 128 0.0050
315 THINKING ABNORMAL 92 0.0049
316 DISTURBANCE IN ATTENTION 265 0.0049
317 DRUG ERUPTION 87 0.0049
318 PSYCHOMOTOR HYPERACTIVITY 81 0.0049
319 CARDIAC PACEMAKER INSERTION 29 0.0049
320 GESTATIONAL DIABETES 23 0.0048
321 DYSKINESIA 196 0.0048
322 DRUG LEVEL ABOVE THERAPEUTIC 22 0.0048
323 SUBCUTANEOUS ABSCESS 23 0.0048
324 EXPOSURE DURING PREGNANCY 297 0.0048
325 PARANOIA 82 0.0048
326 LEUKOCYTOSIS 86 0.0047
327 OFF LABEL USE 4083 0.0047
328 ASPIRATION 51 0.0047
329 STEVENS-JOHNSON SYNDROME 103 0.0046
330 APNOEA 36 0.0046
331 SUBDURAL HAEMATOMA 66 0.0046
332 APATHY 67 0.0046
333 ERYSIPELAS 23 0.0046
334 PERONEAL NERVE PALSY 26 0.0046
335 RESPIRATORY DEPRESSION 56 0.0046
336 BLEPHAROSPASM 28 0.0044
337 TREMOR 737 0.0044
338 VITAMIN D DEFICIENCY 43 0.0044
339 TIC 24 0.0044
340 FALL 1436 0.0043
341 HYPERACUSIS 16 0.0043
342 SALIVARY HYPERSECRETION 43 0.0043
343 DELIRIUM 148 0.0043
344 RESTLESSNESS 156 0.0043
345 BENIGN PROSTATIC HYPERPLASIA 22 0.0043
346 HYPOTHERMIA 43 0.0042
347 ACUTE HEPATIC FAILURE 58 0.0042
348 SUICIDAL IDEATION 386 0.0042
349 MENTAL STATUS CHANGES 117 0.0042
350 DEVELOPMENTAL DELAY 38 0.0042
351 MENINGITIS 28 0.0042
352 LETHARGY 240 0.0042
353 THERAPY PARTIAL RESPONDER 64 0.0041
354 HAND FRACTURE 29 0.0041
355 ERYTHEMA MULTIFORME 38 0.0041
356 PRODUCT SUPPLY ISSUE 29 0.0041
357 PRODUCT USE ISSUE 760 0.0040
358 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114 0.0040
359 HYPERTONIA 23 0.0040
360 VISUAL FIELD DEFECT 29 0.0040
361 CONFUSIONAL STATE 642 0.0040
362 TOXIC EPIDERMAL NECROLYSIS 60 0.0039
363 TOXICITY TO VARIOUS AGENTS 665 0.0039
364 TREATMENT NONCOMPLIANCE 215 0.0039
365 MOOD ALTERED 107 0.0039
366 PRODUCT PRESCRIBING ERROR 93 0.0039
367 BLOOD CREATINE PHOSPHOKINASE INCREASED 112 0.0039
368 JOINT DISLOCATION 41 0.0039
369 FEELING OF DESPAIR 18 0.0039
370 LOSS OF CONSCIOUSNESS 491 0.0038
371 LACERATION 36 0.0038
372 MOUTH SWELLING 22 0.0038
373 DISORIENTATION 151 0.0038
374 DELUSION 59 0.0038
375 HALLUCINATION, AUDITORY 60 0.0038
376 VERTIGO 230 0.0038
377 EOSINOPHILIA 66 0.0038
378 AGRANULOCYTOSIS 70 0.0038
379 UPPER LIMB FRACTURE 75 0.0038
380 AORTIC VALVE INCOMPETENCE 16 0.0038
381 GAMMA-GLUTAMYLTRANSFERASE INCREASED 83 0.0037
382 SHOCK 86 0.0037
383 ELECTROCARDIOGRAM ABNORMAL 29 0.0037
384 PARKINSONISM 36 0.0037
385 LOSS OF LIBIDO 33 0.0037
386 HOSPITALISATION 561 0.0036
387 TIBIA FRACTURE 17 0.0036
388 SKIN WARM 21 0.0036
389 INITIAL INSOMNIA 37 0.0036
390 VENTRICULAR FIBRILLATION 40 0.0036
391 HALLUCINATION 271 0.0036
392 ARRHYTHMIA 170 0.0036
393 SKIN LACERATION 39 0.0036
394 HYPOKINESIA 52 0.0036
395 THERAPY NON-RESPONDER 161 0.0036
396 PAROSMIA 27 0.0036
397 PRESCRIBED UNDERDOSE 71 0.0036
398 RIB FRACTURE 73 0.0035
399 ILEUS 44 0.0035
400 PRODUCT DOSE OMISSION 231 0.0035
401 CARDIO-RESPIRATORY ARREST 147 0.0035
402 DYSGRAPHIA 23 0.0035
403 WALKING AID USER 23 0.0035
404 TREATMENT FAILURE 289 0.0035
405 CIRCULATORY COLLAPSE 59 0.0035
406 TRANSAMINASES INCREASED 77 0.0035
407 PRODUCT PRESCRIBING ISSUE 75 0.0034
408 SUBARACHNOID HAEMORRHAGE 35 0.0034
409 DECUBITUS ULCER 28 0.0034
410 GAIT DISTURBANCE 650 0.0034
411 DIZZINESS 1693 0.0034
412 VENTRICULAR EXTRASYSTOLES 35 0.0034
413 MITRAL VALVE INCOMPETENCE 38 0.0034
414 FRUSTRATION TOLERANCE DECREASED 27 0.0033
415 POLYNEUROPATHY 40 0.0033
416 PRODUCT SUBSTITUTION ISSUE 192 0.0033
417 BIPOLAR DISORDER 36 0.0033
418 CEREBRAL ISCHAEMIA 17 0.0033
419 FAECALOMA 18 0.0033
420 SOCIAL AVOIDANT BEHAVIOUR 19 0.0033
421 CRYING 119 0.0033
422 BEDRIDDEN 43 0.0033
423 INTENTIONAL SELF-INJURY 66 0.0033
424 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 232 0.0033
425 MENTAL IMPAIRMENT 79 0.0033
426 PANCREATITIS ACUTE 73 0.0032
427 INTRACRANIAL PRESSURE INCREASED 18 0.0032
428 AFFECT LABILITY 31 0.0032
429 DRUG INEFFECTIVE 4243 0.0032
430 PERFORMANCE STATUS DECREASED 15 0.0032
431 HYPOTONIA 32 0.0032
432 BRAIN FOG 50 0.0032
433 REBOUND EFFECT 36 0.0032
434 ROAD TRAFFIC ACCIDENT 133 0.0032
435 URINARY INCONTINENCE 94 0.0032
436 FACIAL PARALYSIS 27 0.0032
437 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 28 0.0032
438 RHABDOMYOLYSIS 132 0.0032
439 HYPERCALCAEMIA 39 0.0032
440 DEPRESSION 718 0.0032
441 HIP SURGERY 17 0.0031
442 ACUTE RESPIRATORY FAILURE 60 0.0031
443 HYPOAESTHESIA ORAL 47 0.0031
444 SEASONAL ALLERGY 44 0.0031
445 ADVERSE DRUG REACTION 279 0.0031
446 SINUS TACHYCARDIA 44 0.0031
447 VISION BLURRED 425 0.0031
448 DRUG-INDUCED LIVER INJURY 97 0.0031
449 AUTISM SPECTRUM DISORDER 17 0.0031
450 POISONING DELIBERATE 29 0.0031
451 THROMBOCYTOPENIA 342 0.0031
452 CATATONIA 16 0.0030
453 NEOPLASM 35 0.0030
454 CEREBRAL HAEMORRHAGE 109 0.0030
455 CATARACT OPERATION 18 0.0030
456 HYPOKALAEMIA 140 0.0030
457 LEUKOPENIA 151 0.0030
458 RASH MACULO-PAPULAR 67 0.0030
459 FEAR 81 0.0030
460 MATERNAL DRUGS AFFECTING FOETUS 23 0.0030
461 PANIC ATTACK 109 0.0030
462 RESPIRATORY ARREST 82 0.0030
463 NEPHROLITHIASIS 136 0.0030
464 GASTROENTERITIS VIRAL 53 0.0029
465 DEMENTIA 82 0.0029
466 MUSCLE SPASTICITY 36 0.0029
467 HICCUPS 24 0.0029
468 MYDRIASIS 37 0.0029
469 SYNCOPE 288 0.0029
470 URINARY RETENTION 96 0.0029
471 MAJOR DEPRESSION 21 0.0029
472 PRODUCT ADMINISTRATION ERROR 58 0.0029
473 MANIA 47 0.0029
474 THERAPY CHANGE 28 0.0028
475 PHOTOPSIA 18 0.0028
476 ACCIDENT 34 0.0028
477 SLEEP APNOEA SYNDROME 54 0.0028
478 THERMAL BURN 20 0.0028
479 IMPAIRED DRIVING ABILITY 32 0.0028
480 DYSPHAGIA 267 0.0028
481 FACIAL PAIN 25 0.0028
482 VENTRICULAR SEPTAL DEFECT 16 0.0028
483 SEPTIC SHOCK 121 0.0028
484 TACHYCARDIA 246 0.0028
485 PHOTOPHOBIA 52 0.0028
486 DRUG INTOLERANCE 267 0.0028
487 LYMPHOEDEMA 19 0.0027
488 DEPRESSED MOOD 145 0.0027
489 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 47 0.0027
490 SUDDEN DEATH 29 0.0027
491 EUPHORIC MOOD 28 0.0027
492 DISABILITY 54 0.0027
493 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 26 0.0027
494 EATING DISORDER 58 0.0027
495 SOPOR 36 0.0027
496 DERMATITIS ALLERGIC 34 0.0027
497 PELVIC FRACTURE 21 0.0027
498 HEPATIC ENCEPHALOPATHY 25 0.0027
499 MOVEMENT DISORDER 86 0.0027
500 TORSADE DE POINTES 21 0.0027
501 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 20 0.0027
502 HEPATITIS CHOLESTATIC 16 0.0027
503 LOWER LIMB FRACTURE 51 0.0027
504 HEPATIC FUNCTION ABNORMAL 99 0.0026
505 PRODUCT DOSE OMISSION ISSUE 774 0.0026
506 LIGAMENT SPRAIN 26 0.0026
507 MYOCARDITIS 30 0.0026
508 DISSOCIATION 20 0.0026
509 PHOTOSENSITIVITY REACTION 43 0.0026
510 SLEEP DISORDER 183 0.0026
511 WRIST FRACTURE 31 0.0026
512 RESPIRATORY FAILURE 188 0.0026
513 EMOTIONAL DISORDER 79 0.0026
514 SCRATCH 27 0.0026
515 INCONTINENCE 27 0.0026
516 POISONING 32 0.0025
517 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 15 0.0025
518 MENTAL DISORDER 110 0.0025
519 MEDICATION ERROR 140 0.0025
520 NIGHTMARE 87 0.0025
521 SPINAL OSTEOARTHRITIS 22 0.0025
522 MALNUTRITION 28 0.0025
523 OBSESSIVE-COMPULSIVE DISORDER 20 0.0025
524 PETECHIAE 26 0.0025
525 GAIT INABILITY 83 0.0025
526 INCOHERENT 16 0.0025
527 CONDITION AGGRAVATED 750 0.0025
528 PRODUCT USE IN UNAPPROVED INDICATION 611 0.0025
529 INCREASED APPETITE 47 0.0025
530 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
531 REFUSAL OF TREATMENT BY PATIENT 16 0.0024
532 PARALYSIS 35 0.0024
533 SENSORY DISTURBANCE 39 0.0024
534 TOXIC SKIN ERUPTION 24 0.0024
535 IMMUNOSUPPRESSION 21 0.0024
536 GRAFT VERSUS HOST DISEASE 17 0.0024
537 LIMB INJURY 64 0.0024
538 CEREBROVASCULAR ACCIDENT 398 0.0023
539 ADVERSE REACTION 31 0.0023
540 HIP FRACTURE 75 0.0023
541 URINARY TRACT INFECTION 397 0.0023
542 METASTASES TO CENTRAL NERVOUS SYSTEM 30 0.0023
543 URINE OUTPUT DECREASED 20 0.0023
544 TINNITUS 104 0.0023
545 ANKLE FRACTURE 35 0.0023
546 DYSSTASIA 66 0.0023
547 MUSCLE RIGIDITY 27 0.0023
548 ANXIETY 641 0.0023
549 INSOMNIA 595 0.0022
550 HEPATITIS 57 0.0022
551 COAGULOPATHY 37 0.0022
552 ERECTILE DYSFUNCTION 57 0.0022
553 HYPOCALCAEMIA 42 0.0022
554 LIPASE INCREASED 17 0.0022
555 FOOT FRACTURE 42 0.0022
556 HAEMOLYSIS 17 0.0022
557 ACCIDENTAL OVERDOSE 80 0.0022
558 SEROTONIN SYNDROME 42 0.0022
559 THERAPEUTIC RESPONSE UNEXPECTED 98 0.0022
560 NO ADVERSE EVENT 394 0.0022
561 HYPOTENSION 434 0.0022
562 RASH GENERALISED 56 0.0022
563 FORMICATION 15 0.0022
564 DECREASED APPETITE 500 0.0022
565 DISEASE RECURRENCE 102 0.0021
566 DECREASED ACTIVITY 23 0.0021
567 HEPATIC ENZYME INCREASED 145 0.0021
568 HEPATIC FAILURE 64 0.0021
569 FEEDING DISORDER 43 0.0021
570 BACK INJURY 23 0.0021
571 MYASTHENIA GRAVIS 17 0.0021
572 EAR INFECTION 56 0.0021
573 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 101 0.0021
574 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 424 0.0021
575 HYPOMAGNESAEMIA 29 0.0021
576 ASPHYXIA 17 0.0021
577 HUNGER 29 0.0021
578 PNEUMONIA BACTERIAL 19 0.0021
579 LACTIC ACIDOSIS 67 0.0021
580 LYMPHOPENIA 29 0.0020
581 PULMONARY HAEMORRHAGE 16 0.0020
582 EOSINOPHIL COUNT INCREASED 17 0.0020
583 FEELING ABNORMAL 488 0.0020
584 MIGRAINE 194 0.0020
585 LIVER FUNCTION TEST ABNORMAL 59 0.0020
586 RESPIRATORY RATE INCREASED 18 0.0020
587 VOMITING 953 0.0020
588 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 59 0.0020
589 POLLAKIURIA 84 0.0020
590 JOINT INJURY 43 0.0020
591 LIVER FUNCTION TEST INCREASED 43 0.0020
592 ASPARTATE AMINOTRANSFERASE INCREASED 106 0.0020
593 BLOOD POTASSIUM DECREASED 60 0.0020
594 NERVOUSNESS 104 0.0020
595 HYPOXIA 70 0.0020
596 GASTROENTERITIS 29 0.0020
597 PANCYTOPENIA 111 0.0020
598 LUPUS-LIKE SYNDROME 18 0.0020
599 HEPATOTOXICITY 44 0.0020
600 TASTE DISORDER 40 0.0020
601 CYANOSIS 31 0.0020
602 SLUGGISHNESS 20 0.0020
603 INCREASED TENDENCY TO BRUISE 18 0.0020
604 TRANSIENT ISCHAEMIC ATTACK 66 0.0020
605 HYPOPHAGIA 50 0.0020
606 PNEUMOTHORAX 31 0.0020
607 UROSEPSIS 18 0.0019
608 CHROMATURIA 44 0.0019
609 SPINAL OPERATION 24 0.0019
610 GENERAL PHYSICAL HEALTH DETERIORATION 225 0.0019
611 GENERALISED OEDEMA 24 0.0019
612 BACTERAEMIA 23 0.0019
613 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
614 HEPATIC STEATOSIS 36 0.0019
615 NERVOUS SYSTEM DISORDER 60 0.0019
616 PNEUMONIA 622 0.0019
617 VISUAL IMPAIRMENT 238 0.0019
618 ATRIAL FIBRILLATION 186 0.0019
619 ALANINE AMINOTRANSFERASE INCREASED 117 0.0019
620 TOOTH FRACTURE 21 0.0019
621 SPINAL FRACTURE 38 0.0019
622 COMPLETED SUICIDE 158 0.0019
623 FATIGUE 1474 0.0019
624 ANAL INCONTINENCE 17 0.0019
625 INTENTIONAL PRODUCT USE ISSUE 165 0.0019
626 SPINAL PAIN 22 0.0019
627 HEAD DISCOMFORT 33 0.0019
628 BLOOD ALKALINE PHOSPHATASE INCREASED 46 0.0019
629 PHARYNGEAL SWELLING 18 0.0018
630 SEPSIS 205 0.0018
631 POLYURIA 15 0.0018
632 SURGERY 107 0.0018
633 GASTRITIS 48 0.0018
634 INTENTIONAL DOSE OMISSION 52 0.0018
635 MIDDLE INSOMNIA 34 0.0018
636 CENTRAL NERVOUS SYSTEM LESION 25 0.0018
637 WEIGHT INCREASED 406 0.0018
638 WEIGHT DECREASED 506 0.0018
639 PANCREATITIS 95 0.0018
640 HYPERKALAEMIA 63 0.0018
641 UNDERDOSE 131 0.0018
642 CARPAL TUNNEL SYNDROME 25 0.0018
643 MUSCULAR WEAKNESS 202 0.0018
644 DEHYDRATION 237 0.0018
645 HAEMATOMA 46 0.0018
646 POST PROCEDURAL COMPLICATION 34 0.0018
647 HEART RATE DECREASED 62 0.0018
648 POOR QUALITY SLEEP 38 0.0018
649 DEVICE RELATED INFECTION 27 0.0018
650 EAR DISCOMFORT 18 0.0018
651 FRACTURE 33 0.0017
652 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 124 0.0017
653 BLOOD MAGNESIUM DECREASED 15 0.0017
654 HEADACHE 1082 0.0017
655 HYPOTHYROIDISM 55 0.0017
656 ARTERIOSCLEROSIS 16 0.0017
657 PALLOR 46 0.0017
658 ADVERSE EVENT 155 0.0017
659 CEREBRAL INFARCTION 41 0.0017
660 OXYGEN SATURATION DECREASED 94 0.0017
661 HAEMORRHAGE INTRACRANIAL 25 0.0017
662 PARAESTHESIA ORAL 24 0.0017
663 DIZZINESS POSTURAL 16 0.0016
664 PYREXIA 569 0.0016
665 BLINDNESS 67 0.0016
666 WOUND INFECTION 18 0.0016
667 CHOKING 32 0.0016
668 UNEVALUABLE EVENT 124 0.0016
669 ABNORMAL DREAMS 45 0.0016
670 IRON DEFICIENCY ANAEMIA 15 0.0016
671 SMALL INTESTINAL OBSTRUCTION 20 0.0016
672 PRODUCT DOSE OMISSION IN ERROR 46 0.0016
673 FUNGAL INFECTION 54 0.0016
674 DRUG EFFECT LESS THAN EXPECTED 24 0.0016
675 NEUTROPENIA 219 0.0016
676 SWOLLEN TONGUE 50 0.0016
677 SECRETION DISCHARGE 20 0.0016
678 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
679 RASH 686 0.0016
680 ILLNESS 162 0.0016
681 THERAPEUTIC RESPONSE DECREASED 95 0.0016
682 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0016
683 INTERVERTEBRAL DISC PROTRUSION 34 0.0016
684 CONTUSION 149 0.0015
685 ACUTE KIDNEY INJURY 236 0.0015
686 FACE OEDEMA 26 0.0015
687 CYSTITIS 49 0.0015
688 ASTHENIA 577 0.0015
689 SKIN CANCER 33 0.0015
690 PALPITATIONS 179 0.0015
691 RESPIRATORY DISTRESS 42 0.0015
692 PRODUCT DISPENSING ERROR 33 0.0015
693 LIVER DISORDER 67 0.0015
694 COVID-19 264 0.0015
695 RESPIRATORY DISORDER 45 0.0015
696 IMPAIRED WORK ABILITY 32 0.0015
697 DYSTONIA 29 0.0015
698 BLOOD UREA INCREASED 25 0.0015
699 FEMUR FRACTURE 46 0.0015
700 MENINGIOMA 23 0.0015
701 FEELING JITTERY 28 0.0015
702 GINGIVAL BLEEDING 20 0.0015
703 ELECTROLYTE IMBALANCE 17 0.0015
704 PRODUCT USE COMPLAINT 23 0.0015
705 OSTEOPOROSIS 60 0.0015
706 BLOOD PRESSURE ABNORMAL 29 0.0015
707 RETCHING 31 0.0015
708 COMPLICATION ASSOCIATED WITH DEVICE 21 0.0014
709 VIRAL INFECTION 48 0.0014
710 HEPATIC CIRRHOSIS 27 0.0014
711 HEART RATE INCREASED 142 0.0014
712 BLOOD IRON DECREASED 17 0.0014
713 CONSTIPATION 312 0.0014
714 SKIN INFECTION 16 0.0014
715 RESPIRATORY TRACT INFECTION 37 0.0014
716 HAEMATOCRIT DECREASED 28 0.0014
717 BREAST PAIN 15 0.0014
718 DRY MOUTH 114 0.0014
719 RENAL IMPAIRMENT 118 0.0014
720 MICTURITION URGENCY 16 0.0014
721 HYPOAESTHESIA 209 0.0014
722 ERUCTATION 27 0.0014
723 IMPAIRED GASTRIC EMPTYING 19 0.0014
724 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
725 TOOTHACHE 25 0.0014
726 DEAFNESS 36 0.0014
727 BODY TEMPERATURE INCREASED 28 0.0014
728 HEART RATE IRREGULAR 31 0.0014
729 COLD SWEAT 24 0.0014
730 MUSCLE TIGHTNESS 22 0.0014
731 PRESYNCOPE 33 0.0014
732 DENTAL CARIES 15 0.0014
733 EAR PAIN 26 0.0013
734 NEPHROPATHY TOXIC 15 0.0013
735 SKIN FISSURES 26 0.0013
736 RASH PRURITIC 72 0.0013
737 CARDIOGENIC SHOCK 19 0.0013
738 IMPAIRED QUALITY OF LIFE 19 0.0013
739 RESTLESS LEGS SYNDROME 24 0.0013
740 INFECTION 190 0.0013
741 NO THERAPEUTIC RESPONSE 16 0.0013
742 DRUG DOSE OMISSION 216 0.0013
743 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
744 ORAL PAIN 29 0.0013
745 LIP SWELLING 43 0.0013
746 PHARYNGITIS 16 0.0013
747 HYPERSENSITIVITY 237 0.0013
748 GASTROINTESTINAL DISORDER 114 0.0013
749 DEATH 1096 0.0013
750 ANAEMIA 241 0.0013
751 LIVER INJURY 31 0.0013
752 MUSCLE ATROPHY 16 0.0013
753 PRODUCT TASTE ABNORMAL 17 0.0013
754 OSTEOPENIA 19 0.0013
755 PLATELET COUNT DECREASED 133 0.0012
756 INTESTINAL OBSTRUCTION 47 0.0012
757 LYMPHADENOPATHY 44 0.0012
758 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 224 0.0012
759 PERIPHERAL COLDNESS 17 0.0012
760 HYPOGLYCAEMIA 60 0.0012
761 MOUTH ULCERATION 26 0.0012
762 BLOOD POTASSIUM INCREASED 20 0.0012
763 THIRST 22 0.0012
764 THERAPY CESSATION 63 0.0012
765 NAUSEA 968 0.0012
766 DRY EYE 61 0.0012
767 INFLUENZA 136 0.0012
768 EYE DISORDER 40 0.0012
769 ORAL CANDIDIASIS 16 0.0012
770 WITHDRAWAL SYNDROME 51 0.0012
771 ACTIVITIES OF DAILY LIVING IMPAIRED 24 0.0012
772 DISEASE PROGRESSION 143 0.0012
773 HYPERGLYCAEMIA 44 0.0012
774 THROMBOSIS 97 0.0012
775 CYTOKINE RELEASE SYNDROME 24 0.0012
776 PARAESTHESIA 188 0.0012
777 ULCER 19 0.0012
778 MULTIPLE SCLEROSIS 57 0.0012
779 RENAL FAILURE 158 0.0012
780 CANDIDA INFECTION 20 0.0012
781 DRUG EFFECT INCOMPLETE 43 0.0012
782 ALOPECIA 232 0.0012
783 INJURY 83 0.0012
784 ISCHAEMIC STROKE 21 0.0012
785 HYPERTHYROIDISM 17 0.0012
786 LYMPHOMA 18 0.0012
787 BLOOD PRESSURE INCREASED 178 0.0012
788 WHITE BLOOD CELL COUNT DECREASED 126 0.0012
789 PROTEINURIA 22 0.0012
790 ECZEMA 60 0.0011
791 INCORRECT DOSE ADMINISTERED 260 0.0011
792 STOMATITIS 69 0.0011
793 SWELLING FACE 74 0.0011
794 NEUROPATHY PERIPHERAL 108 0.0011
795 CONJUNCTIVITIS 21 0.0011
796 SKIN DISCOLOURATION 52 0.0011
797 LIMB DISCOMFORT 35 0.0011
798 NECK PAIN 63 0.0011
799 SYSTEMIC LUPUS ERYTHEMATOSUS 40 0.0011
800 CATARACT 67 0.0011
801 WHITE BLOOD CELL COUNT INCREASED 43 0.0011
802 FEELING COLD 31 0.0011
803 UPPER RESPIRATORY TRACT INFECTION 51 0.0011
804 AKATHISIA 15 0.0011
805 BLOOD PRESSURE DECREASED 73 0.0011
806 EXTRAPYRAMIDAL DISORDER 27 0.0011
807 RED BLOOD CELL COUNT DECREASED 31 0.0011
808 ABDOMINAL DISTENSION 113 0.0011
809 DYSPHONIA 63 0.0011
810 DIABETES MELLITUS INADEQUATE CONTROL 19 0.0011
811 BLOOD LACTATE DEHYDROGENASE INCREASED 17 0.0011
812 OBESITY 17 0.0011
813 RASH ERYTHEMATOUS 51 0.0011
814 HAEMATEMESIS 27 0.0011
815 STAPHYLOCOCCAL INFECTION 35 0.0011
816 ABASIA 26 0.0011
817 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
818 SKIN DISORDER 35 0.0010
819 MALAISE 460 0.0010
820 DRUG DISPENSING ERROR 16 0.0010
821 HIP ARTHROPLASTY 16 0.0010
822 JAUNDICE 28 0.0010
823 DIARRHOEA 666 0.0010
824 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
825 VISUAL ACUITY REDUCED 34 0.0010
826 HYPOACUSIS 44 0.0010
827 BACTERIAL INFECTION 19 0.0010
828 ANGIOEDEMA 45 0.0010
829 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53 0.0010
830 DEEP VEIN THROMBOSIS 66 0.0010
831 OROPHARYNGEAL PAIN 94 0.0010
832 HYPERTENSION 215 0.0010
833 RENAL DISORDER 47 0.0010
834 CHEST PAIN 186 0.0010
835 MUSCULOSKELETAL DISORDER 19 0.0010
836 LUNG NEOPLASM MALIGNANT 41 0.0010
837 MUSCLE SPASMS 183 0.0010
838 NEOPLASM MALIGNANT 66 0.0010
839 BLOOD CHOLESTEROL INCREASED 46 0.0010
840 BRONCHITIS 73 0.0010
841 CARDIOVASCULAR DISORDER 25 0.0010
842 BONE MARROW FAILURE 20 0.0010
843 CARDIAC FAILURE 79 0.0010
844 THERAPEUTIC PRODUCT EFFECT DECREASED 44 0.0010
845 DYSURIA 36 0.0010
846 MUSCULOSKELETAL STIFFNESS 85 0.0010
847 HYPERHIDROSIS 124 0.0010
848 ACUTE MYELOID LEUKAEMIA 15 0.0010
849 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
850 NEUTROPHIL COUNT DECREASED 39 0.0010
851 HERPES ZOSTER 54 0.0009
852 PRURITUS 360 0.0009
853 BLOOD CREATININE INCREASED 61 0.0009
854 OEDEMA PERIPHERAL 113 0.0009
855 MULTI-ORGAN FAILURE 16 0.0009
856 DYSPEPSIA 91 0.0009
857 FLATULENCE 52 0.0009
858 NASOPHARYNGITIS 169 0.0009
859 TOOTH LOSS 19 0.0009
860 CHOLELITHIASIS 30 0.0009
861 LOCALISED INFECTION 22 0.0009
862 CARDIAC DISORDER 85 0.0009
863 ABDOMINAL DISCOMFORT 152 0.0009
864 LYMPHOCYTE COUNT DECREASED 16 0.0009
865 NEURALGIA 22 0.0009
866 CYTOMEGALOVIRUS INFECTION 15 0.0009
867 DIVERTICULITIS 25 0.0009
868 BLOOD URINE PRESENT 17 0.0009
869 OEDEMA 48 0.0009
870 GLAUCOMA 17 0.0009
871 GASTROOESOPHAGEAL REFLUX DISEASE 71 0.0009
872 HERNIA 17 0.0009
873 SKIN LESION 24 0.0009
874 OSTEOARTHRITIS 37 0.0009
875 PERICARDIAL EFFUSION 20 0.0009
876 OCULAR HYPERAEMIA 41 0.0009
877 ORTHOSTATIC HYPOTENSION 15 0.0009
878 BACK PAIN 199 0.0009
879 PLEURAL EFFUSION 52 0.0009
880 TOOTH DISORDER 19 0.0009
881 PULMONARY EMBOLISM 81 0.0009
882 RASH PAPULAR 19 0.0008
883 PNEUMONITIS 23 0.0008
884 PERIPHERAL SWELLING 130 0.0008
885 RENAL INJURY 25 0.0008
886 DIABETES MELLITUS 64 0.0008
887 COUGH 235 0.0008
888 MOBILITY DECREASED 60 0.0008
889 NEOPLASM PROGRESSION 29 0.0008
890 RASH MACULAR 29 0.0008
891 MYOCARDIAL INFARCTION 144 0.0008
892 WOUND 23 0.0008
893 GASTRIC DISORDER 28 0.0008
894 NIGHT SWEATS 26 0.0008
895 ABDOMINAL PAIN UPPER 166 0.0008
896 FLUID RETENTION 41 0.0008
897 TYPE 2 DIABETES MELLITUS 27 0.0008
898 LACRIMATION INCREASED 24 0.0008
899 BLOOD PRESSURE FLUCTUATION 19 0.0008
900 RHINORRHOEA 51 0.0008
901 PULMONARY OEDEMA 35 0.0008
902 TARDIVE DYSKINESIA 22 0.0008
903 ABDOMINAL PAIN 180 0.0008
904 ILL-DEFINED DISORDER 47 0.0008
905 ORAL HERPES 15 0.0008
906 FLUSHING 78 0.0008
907 ERYTHEMA 157 0.0008
908 CHRONIC KIDNEY DISEASE 58 0.0008
909 SWELLING 71 0.0008
910 FEELING HOT 46 0.0007
911 EPISTAXIS 56 0.0007
912 URTICARIA 125 0.0007
913 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27 0.0007
914 COLITIS 28 0.0007
915 DRUG ABUSE 61 0.0007
916 BURNING SENSATION 51 0.0007
917 ANAPHYLACTIC REACTION 40 0.0007
918 DISCOMFORT 44 0.0007
919 HAEMOGLOBIN DECREASED 74 0.0007
920 DYSPNOEA EXERTIONAL 27 0.0007
921 EXTRA DOSE ADMINISTERED 29 0.0007
922 SNEEZING 16 0.0007
923 PAIN IN EXTREMITY 209 0.0007
924 DYSPNOEA 400 0.0007
925 HAEMORRHAGE 73 0.0007
926 BLISTER 39 0.0007
927 LUNG DISORDER 34 0.0007
928 MULTIPLE SCLEROSIS RELAPSE 47 0.0007
929 AGEUSIA 17 0.0007
930 CELLULITIS 34 0.0007
931 HAEMATURIA 23 0.0007
932 PRODUCTIVE COUGH 32 0.0007
933 INFLUENZA LIKE ILLNESS 55 0.0007
934 BLOOD BILIRUBIN INCREASED 18 0.0007
935 DIABETIC KETOACIDOSIS 16 0.0007
936 SINUSITIS 68 0.0007
937 EYE PAIN 37 0.0007
938 CHILLS 76 0.0006
939 JOINT STIFFNESS 17 0.0006
940 EYE IRRITATION 37 0.0006
941 C-REACTIVE PROTEIN INCREASED 23 0.0006
942 INTERSTITIAL LUNG DISEASE 30 0.0006
943 DRUG EXPOSURE DURING PREGNANCY 21 0.0006
944 FIBROMYALGIA 15 0.0006
945 PAIN 376 0.0006
946 ACNE 46 0.0006
947 FEBRILE NEUTROPENIA 39 0.0006
948 INFLAMMATION 30 0.0006
949 NASAL CONGESTION 34 0.0006
950 ACUTE MYOCARDIAL INFARCTION 17 0.0006
951 LABORATORY TEST ABNORMAL 17 0.0006
952 ARTHRITIS 45 0.0006
953 EXPIRED PRODUCT ADMINISTERED 19 0.0006
954 DYSGEUSIA 42 0.0006
955 ANGINA PECTORIS 16 0.0006
956 WHEEZING 33 0.0006
957 DRUG ADMINISTRATION ERROR 17 0.0006
958 CARDIAC FAILURE CONGESTIVE 44 0.0005
959 RENAL FAILURE ACUTE 23 0.0005
960 CHEST DISCOMFORT 54 0.0005
961 MALIGNANT NEOPLASM PROGRESSION 54 0.0005
962 SKIN EXFOLIATION 44 0.0005
963 BLOOD GLUCOSE DECREASED 25 0.0005
964 BONE PAIN 30 0.0005
965 EYE SWELLING 19 0.0005
966 HOT FLUSH 38 0.0005
967 DRY SKIN 67 0.0005
968 ARTHRALGIA 208 0.0005
969 THROAT IRRITATION 22 0.0005
970 HAEMATOCHEZIA 27 0.0005
971 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
972 PRODUCT QUALITY ISSUE 65 0.0005
973 MUSCULOSKELETAL PAIN 25 0.0005
974 JOINT SWELLING 57 0.0005
975 MYALGIA 80 0.0005
976 ARTHROPATHY 26 0.0005
977 ASTHMA 52 0.0005
978 DRUG EFFECT DECREASED 24 0.0004
979 ACCIDENTAL EXPOSURE TO PRODUCT 41 0.0004
980 BREAST CANCER 37 0.0004
981 DRUG WITHDRAWAL SYNDROME 33 0.0004
982 RECTAL HAEMORRHAGE 16 0.0004
983 DERMATITIS ATOPIC 19 0.0004
984 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
985 BLOOD GLUCOSE INCREASED 67 0.0004
986 PSORIASIS 43 0.0003
987 INFUSION RELATED REACTION 21 0.0003
988 EMOTIONAL DISTRESS 35 0.0003
989 DEVICE MALFUNCTION 20 0.0003
990 DEVICE ISSUE 21 0.0002
991 RHEUMATOID ARTHRITIS 21 0.0002
992 PRODUCT STORAGE ERROR 16 0.0002
993 DRUG DEPENDENCE 26 0.0002
994 INJECTION SITE PAIN 38 0.0001